U.S. Vaccines, Skin Replacements, and Biologics Manufacturing Industry: Analysis, Expanded Financial Benchmarks, Metrics, and Revenue Forecast to 2028 – ResearchAndMarkets.com


DUBLIN–(BUSINESS WIRE)–The “Vaccines, Skin Replacement Products and Biologics Manufacturing Industry (United States): Analytics, Expanded Financial Benchmarks, Metrics and Revenue Forecast to 2028” Plunkett Research Ltd report has been added to from ResearchAndMarkets.com offer.


Historical figures, growth rates and forecasts that will save countless hours of research.

Main conclusions:

  • Vaccines, Skin Replacement Products and Biologics Manufacturing Industry (United States) to reach $53,581,985,788 million by 2029.

  • Vaccines, skin replacement products and biologics manufacturing industry, including average EBITDA, operating ratios and sales per employee.

Main advantages for the customer:

1) Complete overview of an industry’s financial results, ratios, vital statistics and metrics in one package

2) Complete benchmarking of the industry and its top companies

3) Deep industry and company finance

This report presents:

1) Historical data

2) Revenue forecast, growth rate and CAGR

3) Operating ratios

4) Comprehensive data to compare a company to its industry and specific leading companies

5) Compare this industry to all US industries

6) In-depth profiles and historical financial/operating ratios for up to ten major US-based companies

Designed to benefit:

  • Financial analysis and modeling

  • Investment professionals

  • Lenders

  • M&A Advisors

  • Appraisers

  • Advisors

Similar reports are available from the publisher for almost all US industries.

The publisher has built a solid reputation for providing industry analysis and research in a wide range of fields – energy and utilities, finance and investment, healthcare and biotechnology, engineering and research, to name a few. some.

Key data:

  • Industry Summary

  • Historical turnover until 2021

  • Revenues projected to 2029

  • Number of employees 2014-2021

  • Annual growth rate 2021

  • CAGR 2014 to 2021

  • CAGR 2021 to 2029

  • Major American Companies

  • Employment and Establishments

  • Number of companies 2014-2021

  • Number of establishments 2014-2021

  • Employees, 2014-2021

  • Average annual sales per company and per establishment 2014-2021

  • Sales per employee

  • Average annual operating ratios

  • Revenue versus all industries

  • Spending vs. All Industries

  • Profit and income taxes compared to all industries


  • This industry vs. all industries

  • Comparison of revenues, profits and taxes for all industries

  • Sector results, public companies (United States), average of all companies

  • Industry Income Statement, Balance Sheet, Cash Flow Statement, 2014-2021

  • Top Companies Profiled and Ranked

  • Detailed profiles, financial reports, rankings and executive lists of major US-based companies

  • Top Ranked Companies

  • Market capitalization

  • Employees

  • Revenue

  • Net revenue

  • Revenue growth over 3 years

  • Revenue growth over 3 years

  • return on assets

  • Return on equity

  • Return on invested capital

  • List of main companies (public and private)

  • Comparison of major individual public companies to industry averages, 2021

  • Income statements, balance sheets and cash flow statistics

Main topics covered:


II. Industry description for this NAIC code

III. Industry Summary, Current Year (US Data)

IV. Number of jobs and establishments (US data)

V. Financial data for this industry, United States, with revenue projections to 2029

VI. Top Companies Profiled and Ranked

VII. Appendix: Assumptions

VIII. Description and data sources

Companies cited

  • IFF Nutrition & Biosciences

  • CSL Behring LLC

  • Zoetis Inc

  • Janssen Pharmaceuticals Inc.

  • Forever Living Products International Inc.

  • Emergent BioSolutions Inc

  • Halozyme Therapeutics Inc

  • MiMedx Group Inc.

  • Anika Therapeutics Inc

  • Precision Biosciences Inc

For more information on this report, visit https://www.researchandmarkets.com/r/huh2x6


About Author

Comments are closed.